Argenx
ARGX
#396
Rank
C$89.99 B
Marketcap
C$1,438
Share price
0.16%
Change (1 day)
53.57%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): C$22.07

According to Argenx 's latest financial reports the company's current EPS (TTM) is C$21.87. In 2025 the company made an earnings per share (EPS) of C$29.16 an increase over its 2024 EPS that were of C$19.26.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$22.07-24.32%
2025C$29.1651.44%
2024C$19.26-369.77%
2023C-$7.14-60.46%
2022C-$18.0563.33%
2021C-$11.05-40.37%
2020C-$18.54183.47%
2019C-$6.54123.09%
2018C-$2.9354.93%
2017C-$1.8914.07%
2016C-$1.6613.05%
2015C-$1.47-36.34%
2014C-$2.30209.04%
2013C-$0.75-33.99%
2012C-$1.13185.59%
2011C-$0.40